TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T37693	Cannabinoid receptor 2	B23FTW	Chembl4210152	Investigative	145965919	C24H23ClN2O	390.9	C1CCN(C1)C2=CC=CC(=C2)C3=CC(=CC=C3)NC(=O)CC4=CC=C(C=C4)Cl	Ki ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	B2SAV9	Schembl20599319	Investigative	73353637	C26H39NO2	397.6	CC/C=C\\C/C=C\\C/C=C\\CCCCCCCC(=O)NCC1=CC(=CC=C1)OC	Ki ~ 50000 nM	Poor binder
T37693	Cannabinoid receptor 2	B3G1DN	(1S,2S)-2-(4-(5-((5-Chloropyridin-2-yl)thio)-1-methyl-1H-imidazol-4-yl)phenyl)-N,N-dimethylcyclopropanecarboxamide	Investigative	46909057	C21H21ClN4OS	412.9	CN1C=NC(=C1SC2=NC=C(C=C2)Cl)C3=CC=C(C=C3)[C@H]4C[C@@H]4C(=O)N(C)C	IC50 = 150000 nM	Poor binder
T37693	Cannabinoid receptor 2	B3RS0D	N-[2-(2-Chlorophenyl)-3-(4-chlorophenyl)-5,6,7,8-tetrahydrooxepino[3,2-c]pyrazol-8-yl]-2-methylsulfonylacetamide	Investigative	60150698	C22H21Cl2N3O4S	494.4	CS(=O)(=O)CC(=O)NC1CCCOC2=C(N(N=C12)C3=CC=CC=C3Cl)C4=CC=C(C=C4)Cl	Ki = 59000 nM	Poor binder
T37693	Cannabinoid receptor 2	B53JVD	N-(1-Adamantyl)-7-methylsulfanyl-1-(2-morpholin-4-ylethyl)indole-3-carboxamide	Investigative	137658307	C26H35N3O2S	453.6	CSC1=CC=CC2=C1N(C=C2C(=O)NC34CC5CC(C3)CC(C5)C4)CCN6CCOCC6	EC50 ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	B65AXL	1-[4-[4-[5-(Diethylcarbamoyl)-2-[(4-ethoxyphenyl)methyl]benzimidazol-1-yl]butyl-methylamino]butyl]-2-[(4-ethoxyphenyl)methyl]-N,N-diethylbenzimidazole-5-carboxamide	Investigative	118706314	C51H67N7O4	842.1	CCN(CC)C(=O)C1=CC2=C(C=C1)N(C(=N2)CC3=CC=C(C=C3)OCC)CCCCN(C)CCCCN4C5=C(C=C(C=C5)C(=O)N(CC)CC)N=C4CC6=CC=C(C=C6)OCC	EC50 = 57543.99 nM	Poor binder
T37693	Cannabinoid receptor 2	B70OXR	4-(Cyclopropylamino)-N-(cyclopropylmethyl)-2-(trifluoromethyl)benzenesulfonamide	Investigative	24946181	C14H17F3N2O2S	334.36	C1CC1CNS(=O)(=O)C2=C(C=C(C=C2)NC3CC3)C(F)(F)F	Ki = 86980 nM	Poor binder
T37693	Cannabinoid receptor 2	BAB5X6	CID 12000925	Investigative	12000925	C23H21Cl2N3O2	442.3	C1CC(C2=NN(C(=C2OC1)C3=CC=C(C=C3)Cl)C4=CC=CC=C4Cl)N5CCCC5=O	Ki = 75600 nM	Poor binder
T37693	Cannabinoid receptor 2	BI65BP	N-(Cyclopropylmethyl)-4-(3,5-dimethoxyanilino)-2-(trifluoromethoxy)benzenesulfonamide	Investigative	24948364	C19H21F3N2O5S	446.4	COC1=CC(=CC(=C1)NC2=CC(=C(C=C2)S(=O)(=O)NCC3CC3)OC(F)(F)F)OC	IC50 = 59970 nM	Poor binder
T37693	Cannabinoid receptor 2	BK7S8J	(+/-)-Ibipinabant	Investigative	11179267	C23H20Cl2N4O2S	487.4	CN=C(NS(=O)(=O)C1=CC=C(C=C1)Cl)N2CC(C(=N2)C3=CC=C(C=C3)Cl)C4=CC=CC=C4	Ki = 125892.54 nM	Poor binder
T37693	Cannabinoid receptor 2	BN34RK	N-(1-Adamantyl)-1-(2-morpholin-4-ylethyl)indole-3-carboxamide	Investigative	137640777	C25H33N3O2	407.5	C1COCCN1CCN2C=C(C3=CC=CC=C32)C(=O)NC45CC6CC(C4)CC(C6)C5	IC50 ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	BPF28J	Chembl4206416	Investigative	145978111	C22H22ClN5O	407.9	C1CCN(C1)C2=CC=CC(=N2)NC3=CC(=CC=C3)NC(=O)NC4=CC=C(C=C4)Cl	Ki = 52600 nM	Poor binder
T37693	Cannabinoid receptor 2	BRUH03	Chembl4203175	Investigative	145977995	C23H23ClN4O	406.9	C1CCN(C1)C2=CC=CC(=C2)NC3=CC(=CC=C3)NC(=O)NC4=CC=C(C=C4)Cl	Ki ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	BSLP23	N-(1-Adamantyl)-7-methoxy-1-(2-morpholin-4-ylethyl)indole-3-carboxamide	Investigative	137644344	C26H35N3O3	437.6	COC1=CC=CC2=C1N(C=C2C(=O)NC34CC5CC(C3)CC(C5)C4)CCN6CCOCC6	EC50 ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	BUD8W7	Chembl4176556	Investigative	145972916	C25H20O4	384.4	C1=CC=C2C(=C1)C=CC=C2C(=O)C3=CC=C(C4=CC=CC=C43)OCCCC(=O)O	IC50 ~ 100000 nM	Poor binder
T37693	Cannabinoid receptor 2	BY28FL	1-(6-(2-Chloropyridin-4-yl)-5-(4-(trifluoromethyl)phenyl)pyrazin-2-yl)-3-(ethylamino)azetidine-3-carboxamide	Investigative	44576715	C22H20ClF3N6O	476.9	CCNC1(CN(C1)C2=CN=C(C(=N2)C3=CC(=NC=C3)Cl)C4=CC=C(C=C4)C(F)(F)F)C(=O)N	Ki ~ 50000 nM	Poor binder
T37693	Cannabinoid receptor 2	D0ZU9Z	LY320135	Investigative	5311257	C24H17NO4	383.4	COC1=CC=C(C=C1)C2=C(C3=C(O2)C=C(C=C3)OC)C(=O)C4=CC=C(C=C4)C#N	Ki = 67608.3 nM	Poor binder